Candel Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.27 | -100% | -14.33 | -100% |
| P/S |
|
1064.07 | 33.44 | 3082.48% |
|
|
| P/BV |
|
2.59 | 4.64 | -44.26% |
|
|
| P/FCF |
|
0 | 42.53 | -100% |
|
|
| Ev/Ebitda |
|
-0.5468 | -17.68 | -96.91% |
|
|
| Ev/S |
|
655.98 | 22.59 | 2803.26% |
|
|
| Ev/FCF |
|
-0.586 | 47.55 | -101.23% |
|
|
| E/P |
|
0 | 0.0182 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-119970.97 | -14.2 | 844543.21% | -58006.59 | +106.82% |
| ROE |
|
-297.68 | 9.78 | -3142.9% |
|
|
| ROA |
|
-90.98 | 0.33 | -27664.55% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-122383.87 | -26.41 | 463234.25% |
|
|
| ROCE |
|
-301.22 | 14.5 | -2177.12% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.5859 | -3.87 | -84.87% | -0.6224 | -5.87% |
| Nеt Debt/Ebitda |
|
0.3402 | -4.24 | -108.02% |
|
|
| Debt/Ratio |
|
0.5225 | 0.1853 | 181.98% |
|
|
| Debt/Equity |
|
0 | 1.56 | -100% |
|
|
| Debt/Net Income |
|
-0.5743 | 10.06 | -105.71% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5351 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.235 | -100% |
|
|
| Average dividend growth |
|
0 | 1.41 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.486 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5351 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-75.2 | 30.62 | -345.59% | ||
| Growth impulse Ebitda in 5 years |
|
392.51 | -17.42 | -2353.21% | ||
| Growth impulse Net Income in 5 years |
|
374.24 | -52.26 | -816.11% | ||
| Growth impulse FCF in 5 years |
|
554.74 | -31.68 | -1851.07% | ||
| Growth impulse EPS in 5 years |
|
205.63 | -61.82 | -432.63% |
IP Score
4.26/10
